Intimation of participation in the Investor Conferences
Awaiting price reaction for this filing.
Mankind Pharma has informed stock exchanges about its participation in two upcoming investor conferences in London. The first is the India Corporate Day organized by Kotak on June 23, 2025, followed by the IIFL 9th Invest India Conference on June 24-25, 2025. Both events will feature one-on-one and group meetings between company officials and investors. The company clarified that no unpublished price sensitive information (UPSI) will be shared at these conferences. The schedule may change due to unforeseen circumstances. The filing was made under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
This is a routine disclosure showing management's active engagement with institutional investors, which may help improve visibility among foreign portfolio investors. Since no UPSI will be shared, the conferences are unlikely to cause any immediate material movement in the stock price.